Twist Bioscience Corporation · NASDAQ:TWST

Leproust Emily M. sold 356,546 Twist Bioscience Corporation shares (Form 4)

Traded Sep 17, 2026 · Filed Sep 21, 2026

On Sep 17, 2026, Leproust Emily M. (Director, Chief Executive Officer) sold 356,546 Twist Bioscience Corporation shares at an average US$157.99 for US$56.3M under a trading plan, leaving 620,589 shares. Filed Sep 21, 2026 (Form 4).

Sold
356,546 shares
Price
US$157.99 average (US$151.46 to US$163.39)
Value
US$56.3M
Holding after
620,589 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 17, 2026Common StockOption exercise133,269US$26.66901,696Direct
Sep 17, 2026Common StockOption exercise75,439US$8.82977,135Direct
Sep 17, 2026Common StockSale2,440US$151.46974,695Direct
Sep 17, 2026Common StockSale6,644US$152.21968,051Direct
Sep 17, 2026Common StockSale3,399US$153.40964,652Direct
Sep 17, 2026Common StockSale4,175US$154.17960,477Direct
Sep 17, 2026Common StockSale13,378US$155.46947,099Direct
Sep 17, 2026Common StockSale9,097US$156.47938,002Direct
Sep 17, 2026Common StockSale32,260US$157.49905,742Direct
Sep 17, 2026Common StockSale232,173US$158.09673,569Direct
Sep 17, 2026Common StockSale23,884US$159.53649,685Direct
Sep 17, 2026Common StockSale14,493US$160.44635,192Direct
Sep 17, 2026Common StockSale11,169US$161.49624,023Direct
Sep 17, 2026Common StockSale2,565US$162.31621,458Direct
Sep 17, 2026Common StockSale869US$163.39620,589Direct

Source

View original at SEC

Related